In recent years, microplastics have emerged as a global environmental concern, not only for ecosystems but also for human health. These tiny plastic particles, often less than 5 millimetres in size, ...

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Novo Nordisk received approval from the Food and Drug Administration for three new indications of Sogroya, a growth hormone.

Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Objectives To investigate the potential long-term impacts of adult growth hormone deficiency (GHD). Design Observational, retrospective matched cohort. Setting UK Clinical Practice Research Datalink ...

Scaling a company across borders is difficult. Scaling one whose “product” is human transformation—delivered live, in real time, through conversation—would seem nearly impossible. Yet Landmark, one of ...